Feb 2012 $16 M No. 7 $10 to $50 million 8
Lux Biosciences Inc.: Raise no. 7, Feb 2012 × Investors in this round 8 investors had bought by the notice of Mar 6, 2012: 8 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $16 M of $17 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice A. Clarke Atwell · Executive Officer Eddy Anglade · Executive Officer Axel Clarke Bolte · Director David Clarke Guyer · Director David Clarke Schnell · Director Dean Clarke Mitchell · Director Lutz Clarke Giebel · Director Paul Clarke Chaney · Director Thomas Clarke Dyrberg · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by George Eldridge, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 6, 2012. Read the notice at the SEC .
debt, options SEC Dec 2011 $4 M No. 6 $2 to $10 million 10
Lux Biosciences Inc.: Raise no. 6, Dec 2011 × Investors in this round 10 investors had bought by the notice of Dec 12, 2011: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice A. Clarke Atwell · Executive Officer Eddy Anglade · Executive Officer Axel Clarke Bolte · Director David Clarke Guyer · Director David Clarke Schnell · Director Dean Clarke Mitchell · Director Lutz Clarke Giebel · Director Paul Clarke Chaney · Director Thomas Clarke Dyrberg · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by George Eldridge, Chief Financial Officer. Source: SEC Form D, newest notice filed Dec 12, 2011. Read the notice at the SEC .
debt, options SEC Jun 2011 $6 M No. 5 $2 to $10 million 10
Lux Biosciences Inc.: Raise no. 5, Jun 2011 × Investors in this round 10 investors had bought by the notice of Jul 14, 2011: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $6 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice A. Clarke Atwell · Executive Officer Dean Clarke Mitchell · Executive Officer, Director Eddy Anglade · Executive Officer Axel Clarke Bolte · Director David Clarke Guyer · Director David Clarke Schnell · Director Lutz Clarke Giebel · Director Paul Clarke Chaney · Director Thomas Clarke Dyrberg · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by George Eldridge, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 14, 2011. Read the notice at the SEC .
debt, options SEC Mar 2011 $3 M No. 4 $2 to $10 million 10
Lux Biosciences Inc.: Raise no. 4, Mar 2011 × Investors in this round 10 investors had bought by the notice of Mar 18, 2011: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $5 M offered; $2 M still to sell
Smallest investment taken $6,916
What was sold debt, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice A. Clarke Atwell · Executive Officer Dean J Mitchell · Executive Officer, Director Eddy Clarke Anglade · Executive Officer George J Eldridge · Executive Officer Axel Clarke Bolte · Director David Clarke Guyer · Director David G. Schnell · Director Lutz Clarke Giebel · Director Paul G. Chaney · Director Thomas Clarke Dyrberg · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by George Eldridge, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 18, 2011. Read the notice at the SEC .
debt, options SEC Dec 2010 $5 M No. 3 $2 to $10 million 10
Lux Biosciences Inc.: Raise no. 3, Dec 2010 × Investors in this round 10 investors had bought by the notice of Dec 20, 2010: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken $11,526
What was sold debt, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue No revenue
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice A. Clarke Atwell · Executive Officer Dean J Mitchell · Executive Officer, Director Eddy Clarke Anglade · Executive Officer George J Eldridge · Executive Officer Axel Clarke Bolte · Director David Clarke Guyer · Director David G. Schnell · Director Lutz Clarke Giebel · Director Paul G. Chaney · Director Thomas Clarke Dyrberg · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by George Eldridge, Chief Financial Officer. Source: SEC Form D, newest notice filed Dec 20, 2010. Read the notice at the SEC .
debt, options SEC Oct 2009 $38 M No. 2 $10 to $50 million 10
Lux Biosciences Inc.: Raise no. 2, Oct 2009 × Investors in this round 10 investors had bought by the notice of Oct 30, 2009: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $38 M of $50 M offered; $12 M still to sell
Smallest investment taken $87,302
What was sold equity
Meant to last a year or less
Issuer's revenue No revenue
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice A. Clarke Atwell · Executive Officer Brett Clarke Skolnik · Executive Officer Eddy Clarke Anglade · Executive Officer Ulrich M. Grau · Executive Officer, Director Axel Clarke Bolte · Director David Clarke Guyer · Director David G. Schnell · Director Lutz Clarke Giebel · Director Paul G. Chaney · Director Thomas Clarke Dyrberg · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Brett Skolnik, Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 30, 2009. Read the notice at the SEC .
equity SEC Jun 2009 $9 M No. 1 $2 to $10 million 10
Lux Biosciences Inc.: Raise no. 1, Jun 2009 × Investors in this round 10 investors had bought by the notice of Jun 16, 2009: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $9 M of $9 M offered
Smallest investment taken $21,167
What was sold debt, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue No revenue
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice A. Clarke Atwell · Executive Officer Brett Skolnik · Executive Officer Eddy Anglade · Executive Officer Ulrich M. Grau · Executive Officer, Director Axel Bolte · Director David Guyer · Director David Schnell · Director Lutz Giebel · Director Paul G. Chaney · Director Thomas Dyrberg · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Brett Skolnik, Chief Financial Officer. Source: SEC Form D, newest notice filed Jun 16, 2009. Read the notice at the SEC .
debt, options SEC